Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Interpretation of changes in the T1- and T2-weighted MR images from patients with newly diagnosed glioblastoma (GBM) treated with standard of care in conjunction with anti-angiogenic agents is complicated by pseudoprogression and pseudoresponse. The hypothesis being tested in this study was that 3D...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Sarah J., Li, Yan, Lupo, Janine M., Olson, Marram, Crane, Jason C., Molinaro, Annette, Roy, Ritu, Clarke, Jennifer, Butowski, Nicholas, Prados, Michael, Cha, Soonmee, Chang, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069332/
https://www.ncbi.nlm.nih.gov/pubmed/27535746
http://dx.doi.org/10.1007/s11060-016-2229-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069332/
https://www.ncbi.nlm.nih.gov/pubmed/27535746
http://dx.doi.org/10.1007/s11060-016-2229-3

Ejemplares similares